* Orgenesis Inc ORGS.OQ reported quarterly adjusted earnings
of 1 cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 26 cents per
share.
* Revenue rose 399.9% to $9.39 million from a year ago;
analysts expected $2.80 million.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Orgenesis Inc shares had fallen by 20.6% this quarter and
gained 1.1% so far this year.
* The company reported quarterly net income of $219 thousand.
* Wall Street's median 12-month price target for Orgenesis Inc
is $9.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 7 at 01:34 p.m. GMT. All
figures in US Dollars.